These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 22838251

  • 1. PTEN and MDM2 expression in the prediction of postmolar gestational trophoblastic neoplasia.
    Lertkhachonsuk R, Tantbirojn P, Paiwattananupant K.
    J Reprod Med; 2012; 57(7-8):333-40. PubMed ID: 22838251
    [Abstract] [Full Text] [Related]

  • 2. Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: a case-control study.
    Kim BW, Cho H, Kim H, Nam EJ, Kim SW, Kim S, Kim YT, Kim JH.
    Eur J Obstet Gynecol Reprod Biol; 2012 Jan; 160(1):100-5. PubMed ID: 22055909
    [Abstract] [Full Text] [Related]

  • 3. Influence of hydatidiform mole follow-up setting on postmolar gestational trophoblastic neoplasia outcomes: a cohort study.
    Dantas PR, Maestá I, Cortés-Charry R, Growdon WB, Braga A, Rudge MV, Berkowitz RS.
    J Reprod Med; 2012 Jan; 57(7-8):305-9. PubMed ID: 22838246
    [Abstract] [Full Text] [Related]

  • 4. Gestational trophoblastic neoplasia after spontaneous human chorionic gonadotropin normalization following molar pregnancy evacuation.
    Braga A, Maestá I, Matos M, Elias KM, Rizzo J, Viggiano MG.
    Gynecol Oncol; 2015 Nov; 139(2):283-7. PubMed ID: 26383828
    [Abstract] [Full Text] [Related]

  • 5. Changing presentation of complete hydatidiform mole at the New England Trophoblastic Disease Center over the past three decades: does early diagnosis alter risk for gestational trophoblastic neoplasia?
    Sun SY, Melamed A, Goldstein DP, Bernstein MR, Horowitz NS, Moron AF, Maestá I, Braga A, Berkowitz RS.
    Gynecol Oncol; 2015 Jul; 138(1):46-9. PubMed ID: 25969351
    [Abstract] [Full Text] [Related]

  • 6. Does a human chorionic gonadotropin level of over 20,000 IU/L four weeks after uterine evacuation for complete hydatidiform mole constitute an indication for chemotherapy for gestational trophoblastic neoplasia?
    Braga A, Biscaro A, do Amaral Giordani JM, Viggiano M, Elias KM, Berkowitz RS, Seckl MJ.
    Eur J Obstet Gynecol Reprod Biol; 2018 Apr; 223():50-55. PubMed ID: 29477553
    [Abstract] [Full Text] [Related]

  • 7. Hormonal contraceptive use before hCG remission does not increase the risk of gestational trophoblastic neoplasia following complete hydatidiform mole: a historical database review.
    Braga A, Maestá I, Short D, Savage P, Harvey R, Seckl MJ.
    BJOG; 2016 Jul; 123(8):1330-5. PubMed ID: 26444183
    [Abstract] [Full Text] [Related]

  • 8. Women with a partial mole during their first pregnancy and diagnosed earlier in gestation are at increased risk of developing gestational trophoblastic neoplasia.
    Worley MJ, Joseph NT, Berkowitz RS, Goldstein DP.
    Int J Gynecol Cancer; 2014 Jun; 24(5):941-5. PubMed ID: 24819660
    [Abstract] [Full Text] [Related]

  • 9. Complete hydatidiform mole in women aged 40 to 49 years.
    Elias KM, Shoni M, Bernstein M, Goldstein DP, Berkowitz RS.
    J Reprod Med; 2012 Jun; 57(5-6):254-8. PubMed ID: 22696822
    [Abstract] [Full Text] [Related]

  • 10. Postmolar gestational trophoblastic neoplasia: beyond the traditional risk factors.
    Bakhtiyari M, Mirzamoradi M, Kimyaiee P, Aghaie A, Mansournia MA, Ashrafi-Vand S, Sarfjoo FS.
    Fertil Steril; 2015 Sep; 104(3):649-54. PubMed ID: 26099850
    [Abstract] [Full Text] [Related]

  • 11. Incidence of postmolar gestational trophoblastic disease in androgenetic moles and the morphological features associated with low risk postmolar gestational trophoblastic disease.
    Kaneki E, Kobayashi H, Hirakawa T, Matsuda T, Kato H, Wake N.
    Cancer Sci; 2010 Jul; 101(7):1717-21. PubMed ID: 20518791
    [Abstract] [Full Text] [Related]

  • 12. A Novel Prediction Model for Postmolar Gestational Trophoblastic Neoplasia and Comparison With Existing Models.
    Zhao P, Wang S, Zhang X, Lu W.
    Int J Gynecol Cancer; 2017 Jun; 27(5):1028-1034. PubMed ID: 28498254
    [Abstract] [Full Text] [Related]

  • 13. Combined analysis of clinical features, human chorionic gonadotropin (hCG) value, and hCG ratios for early prediction of postmolar gestational trophoblastic neoplasia.
    Rakprasit C, Ruengkhachorn I, Therasakvichya S, Inthasorn P, Achariyapota V, Kuljarasnont S, Khemworapong K, Jareemit N.
    Arch Gynecol Obstet; 2023 Apr; 307(4):1145-1154. PubMed ID: 36116082
    [Abstract] [Full Text] [Related]

  • 14. Uterine artery Doppler flow velocimetry parameters for predicting gestational trophoblastic neoplasia after complete hydatidiform mole, a prospective cohort study.
    Asmar FTC, Braga-Neto AR, de Rezende-Filho J, Villas-Boas JMS, Charry RC, Maesta I.
    Clinics (Sao Paulo); 2017 May; 72(5):284-288. PubMed ID: 28591340
    [Abstract] [Full Text] [Related]

  • 15. Apoptotic index for prediction of postmolar gestational trophoblastic neoplasia.
    Braga A, Maestá I, Rocha Soares R, Elias KM, Custódio Domingues MA, Barbisan LF, Berkowitz RS.
    Am J Obstet Gynecol; 2016 Sep; 215(3):336.e1-336.e12. PubMed ID: 27094961
    [Abstract] [Full Text] [Related]

  • 16. What is the optimal duration of human chorionic gonadotrophin surveillance following evacuation of a molar pregnancy? A retrospective analysis on over 20,000 consecutive patients.
    Coyle C, Short D, Jackson L, Sebire NJ, Kaur B, Harvey R, Savage PM, Seckl MJ.
    Gynecol Oncol; 2018 Feb; 148(2):254-257. PubMed ID: 29229282
    [Abstract] [Full Text] [Related]

  • 17. Gestational trophoblastic neoplasia after achieving a nondetectable serum human chorionic gonadotrophin level.
    Gueye M, Kane-Gueye SM, Ndiaye-Gueye MD, Mbaye M, Diouf AA, Niang MM, Diallo M, Moreau JC.
    BJOG; 2014 Oct; 121(11):1415-9. PubMed ID: 24674295
    [Abstract] [Full Text] [Related]

  • 18. MicroRNA Expression Profiling in Hydatidiform Mole for the Prediction of Postmolar GTN : MicroRNA Profile in Postmolar GTN.
    Teerapakpinyo C, Areeruk W, Tantbirojn P, Phupong V, Shuangshoti S, Lertkhachonsuk R.
    Technol Cancer Res Treat; 2022 Oct; 21():15330338211067309. PubMed ID: 35023789
    [Abstract] [Full Text] [Related]

  • 19. Reproductive outcomes after hydatiform mole and gestational trophoblastic neoplasia.
    Gadducci A, Lanfredini N, Cosio S.
    Gynecol Endocrinol; 2015 Oct; 31(9):673-8. PubMed ID: 26288335
    [Abstract] [Full Text] [Related]

  • 20. [Expression and significance of LMP2 and PPM1A in gestational trophoblastic disease].
    Zhang SS, Wan XY, Zhou CY, Lü WG, Xie X.
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jul; 46(7):510-5. PubMed ID: 22041443
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.